Rinvoq

Rinvoq is a prescription drug for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ulcerative colitis (UC), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). The drug works by blocking certain signals inside the body's cells that are thought to cause inflammation.

Interest in Rinvoq grew 27% over the past year, compared to the year before, putting it at a current volume of 281K searches per month, as of last month.